Artificial heart valve frame, double-layer artificial heart valve frame and artificial heart valve prosthesis
By designing a foldable upper and lower anchoring structure, the problem of high operational difficulty and low success rate caused by excessively long valve stents in existing technologies has been solved. This enables more flexible angle adjustment and stable anchoring, adapting to different access methods and reducing surgical risks.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- MITRASSIST LIFESCIENCES LTD
- Filing Date
- 2024-05-29
- Publication Date
- 2026-04-14
AI Technical Summary
In current transcatheter mitral valve replacement surgery, the valve stent is difficult to operate with in the transseptal puncture approach mode. The excessive length of the stent leads to a low success rate and it cannot be adapted to patients with complex anatomy or limited space.
Design an artificial heart valve stent comprising an upper anchoring structure and a lower anchoring structure. In the radial contraction state, the upper anchoring structure folds downward and the lower anchoring structure folds upward, shortening the axial length, facilitating angle adjustment and anchoring to the valve annulus, and adapting to different access patterns.
This reduces the difficulty of the surgical procedure, minimizes damage to the patient's tissues, improves the success rate and adaptability of the surgery, and ensures the stable anchoring and functional support of the artificial heart valve.
Smart Images

Figure CN118542758B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the technical field of medical devices, and in particular to a catheter-delivered artificial heart valve stent, a double-layered artificial heart valve stent, and an artificial heart valve prosthesis. Background Technology
[0002] like Figure 1 As shown, in the structure of the human heart, the mitral valve ensures that blood flows from the left atrium to the left ventricle, the tricuspid valve ensures that blood flows from the right atrium to the right ventricle, the interatrial septum is the tissue between the left and right atria, the mitral annulus is the intersection of the tissues between the left atrium, left ventricle and mitral valve leaflets, and the tricuspid annulus is the intersection of the tissues between the right atrium, right ventricle and tricuspid valve leaflets.
[0003] Transcatheter heart valve replacement involves inserting a sheath into the patient's heart to deliver an artificial heart valve prosthesis to the valve annulus region, thereby completing the artificial valve placement and restoring valve function. Transcatheter mitral valve replacement and transcatheter tricuspid valve replacement are used to treat congenital mitral stenosis or regurgitation, as well as tricuspid stenosis or regurgitation.
[0004] Taking mitral regurgitation as an example, due to congenital abnormalities or acquired lesions of the mitral valve, it cannot close completely when the left ventricle contracts, causing some of the blood flowing from the left atrium into the left ventricle to flow back into the left atrium, causing a series of pathological changes and clinical symptoms in the heart, which can lead to heart failure or even death in severe cases.
[0005] Mitral valve replacement surgery involves implanting an artificial valve to replace the original mitral valve, which has lost its function due to disease, thereby improving mitral regurgitation and alleviating or reconstructing the clinical symptoms caused by mitral stenosis.
[0006] Most existing mitral valve replacement stents are cylindrical in shape, and after anchoring, the elasticity of the stent itself provides radial support.
[0007] Existing transcatheter mitral valve replacement (TCV) procedures primarily utilize two approaches: transapical and transfemoral vein approaches. The transfemoral vein and transatrial septal approaches, compared to the transapical approach, result in smaller incisions, lower surgical risks, less patient discomfort, and shorter postoperative healing periods. However, due to the anatomical structure of the human body, the atrial septum and valve annulus plane are either perpendicular or at an angle. Therefore, during stent deployment, after the sheath tip carrying the stent exits from the atrial septum, the angle needs to be adjusted so that the stent-laden sheath tip is centered on the valve annulus and perpendicular to the annulus plane; this is the optimal deployment position. With existing transatrial septal stent deployments, the portion of the sheath containing the stent is relatively rigid after insertion, making bending difficult. Therefore, it needs to be inserted entirely into the atrium before bending, but the limited space in the atrium makes bending a challenging procedure in practice. This increases the failure rate and risk of the procedure. Furthermore, it makes it impossible to perform the procedure via transseptal puncture for some patients with smaller atria after dissection or those who do not have sufficient space for adjustment for other reasons.
[0008] In summary, in the existing technology, the length of the valve stent after compression is relatively long, which greatly limits the surgical approach using the transseptal approach. In particular, for stents that are too long after compression, they can only be used with the transapical approach and cannot be used with the transseptal approach, thus affecting the success rate and feasibility of the surgical procedure. Summary of the Invention
[0009] The technical problem to be solved by the present invention is to provide a transcatheter artificial heart valve stent, a double-layer artificial heart valve stent, and an artificial heart valve prosthesis that are advantageous for shortening length when loaded.
[0010] To solve the above-mentioned technical problems, the embodiments of the present invention adopt the following technical solutions:
[0011] In a first aspect, embodiments of the present invention provide an artificial heart valve stent, comprising a skeleton, an upper anchoring structure, and a lower anchoring structure; the skeleton includes a valve stent body; the upper anchoring structure is connected to the upper end of the skeleton and extends to the outside of the valve stent body; the lower anchoring structure is connected to the lower end of the skeleton and extends to the outside of the valve stent body. When the artificial heart valve stent transitions to a radially contracted state, the upper anchoring structure elastically folds downward and towards the valve stent body; the lower anchoring structure elastically folds upward and towards the valve stent body.
[0012] The artificial heart valve frame includes a valve frame body, meaning the frame may only include the valve frame body, or it may include other connecting structures in addition to the valve frame body. Preferably, but not limited to, the frame also includes a curved portion connected to the upper end of the valve frame body; the curved portion includes an upper curved section extending radially outward and downward and a lower curved section extending radially inward and downward from the lower end of the upper curved section; the upper anchoring structure is connected to the upper curved section.
[0013] Optionally and more preferably, in the radially contracted state of the artificial heart valve, the upper anchoring structure and the lower anchoring structure overlap radially inside and outside the valve body.
[0014] Further optional and more preferably, in the radially contracted state of the artificial heart valve, the lower anchoring structure is located inside the upper anchoring structure in the radial direction of the valve body.
[0015] Furthermore, optionally and preferably, in the radially contracted state of the artificial heart valve stent, the axial lengths of both the upper and lower anchoring structures are not greater than the axial length of the skeleton.
[0016] Optionally and more preferably, the upper anchoring structure is a corolla-shaped structure, wherein the base of each petal unit is connected to the upper end of the skeleton, and the petal tips are arc-shaped free ends.
[0017] Optionally and more preferably, the lower anchoring structure is a corolla-shaped structure, wherein the base of each petal unit is connected to the lower end of the skeleton, and the petal tips are arc-shaped free ends.
[0018] In a second aspect, embodiments of the present invention provide a double-layer artificial heart valve stent, which includes an inner stent and an outer stent, wherein the outer stent is the artificial heart valve stent described in any optional embodiment of the first aspect, and the inner stent is located within the valve stent body.
[0019] Optionally and more preferably, in the radially contracted state of the double-layer artificial heart valve stent, the axial length of the valve body of the outer stent is not greater than the axial length of the inner stent.
[0020] Thirdly, embodiments of the present invention provide an artificial heart valve prosthesis, which includes the double-layer artificial heart valve stent provided in the second aspect above and leaflets connected to the stent.
[0021] Fourthly, embodiments of the present invention provide another artificial heart valve prosthesis, which includes the artificial heart valve frame provided in the first aspect and leaflets connected to the artificial heart valve frame.
[0022] The artificial heart valve stent provided in the first aspect of this invention has the following beneficial effects:
[0023] (1) The upper and lower anchoring structures play an anchoring function after release. During delivery, the artificial heart valve retracts radially within the delivery sheath. At this time, the upper anchoring structure of the artificial heart valve folds down and closer to the valve body, and the lower anchoring structure folds up and closer to the valve body. As a result, the axial length of the artificial heart valve after retraction is shorter, and the length of the hard segment of the delivery sheath after passing through the interatrial septum is smaller and more flexible. The angle adjustment is easier, and even a smaller left atrium can achieve a larger angle adjustment, which improves the adaptability of transseptal puncture implantation of valve prostheses to complex cases and anatomical structures.
[0024] (2) It can also be implanted through the apex of the heart. Regardless of which approach is chosen, the shorter length of the artificial heart valve after contraction can also result in a shorter distance for the delivery sheath to retract during release, which can release faster and reduce the problem of inaccurate anchoring caused by release. All of these greatly reduce the difficulty of the operation, reduce the degree of damage to the patient's tissues, and reduce the risk of the operation.
[0025] (3) After implantation and release into the valve region between the atrium and ventricle, the upper and lower anchoring structures rebound after release. The upper and lower anchoring structures clamp the patient's valve annulus and fit into the heart tissue at the expected release position. This causes no trauma to the heart tissue, and the implantation can achieve long-term anchoring. Furthermore, it maintains the structural morphology of the artificial heart valve prosthesis and provides long-term stable support for the various functions of the artificial heart valve.
[0026] The double-layer artificial heart valve stent provided in the second aspect of the present invention, as well as the artificial heart valve prostheses provided in the third and fourth aspects respectively, each include the artificial heart valve stent provided in the first aspect, and therefore, can achieve all the beneficial effects that the artificial heart valve stent provided in the first aspect can achieve. Attached Figure Description
[0027] To more clearly illustrate the specific embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the specific embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present invention. For those skilled in the art, other drawings can be obtained from these drawings without creative effort.
[0028] Figure 1 A schematic diagram of the human heart's anatomical structure;
[0029] Figure 2A schematic diagram of the overall structure of the artificial heart valve prosthesis provided in the embodiment of the present invention in an inflated state;
[0030] Figure 3 This is an isometric schematic diagram of the overall structure of the artificial heart valve prosthesis in an inflated state, provided in an embodiment of the present invention.
[0031] Figure 4 This is a front view of a local stent structure of an artificial heart valve prosthesis in an inflated state, as provided in an embodiment of the present invention.
[0032] Figure 5 A top view of the overall structure of the artificial heart valve prosthesis provided in an embodiment of the present invention in an inflated state;
[0033] Figure 6 A schematic diagram of the overall structure of the artificial heart valve prosthesis under radial contraction state provided in an embodiment of the present invention;
[0034] Figure 7 This is a schematic diagram of the overall structure of the artificial heart valve prosthesis in the expanded state of the internal stent, as provided in an embodiment of the present invention.
[0035] Icons: 10-Outer support; 11-Petal frame body; 111-Bend; 12-Upper anchoring structure; 121-V-shaped petal unit; 122-Rhomboid petal unit; 123-End connecting rod; 13-Lower anchoring structure; 20-Inner support; 21-V-shaped main support unit; 221-Connecting hole; 22-Auxiliary beam; 30-Petal leaf. Detailed Implementation
[0036] To make the objectives, technical solutions, and advantages of the embodiments of the present invention clearer, the technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. The components of the embodiments of the present invention described and shown in the accompanying drawings can generally be arranged and designed in various different configurations.
[0037] Therefore, the following detailed description of the embodiments of the invention provided in the accompanying drawings is not intended to limit the scope of the claimed invention, but merely to illustrate selected embodiments of the invention. All other embodiments obtained by those skilled in the art based on the embodiments of the invention without inventive effort are within the scope of protection of the invention.
[0038] It should be noted that similar labels and letters in the accompanying drawings indicate similar items. Therefore, once an item is defined in one accompanying drawing, it does not need to be further defined and explained in subsequent accompanying drawings.
[0039] In the description of this invention, it should be noted that the terms "upper end," "lower end," "inner," and "outer," etc., indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings, or the orientation or positional relationship commonly used when the product is in use. These terms are used only for the convenience of describing the invention and for simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation. Therefore, they should not be construed as limitations on the invention. Specifically, in this embodiment, after the artificial heart valve stent or artificial heart valve prosthesis is delivered via catheter and implanted into the patient, the upstream end in the direction of blood flow is considered the upper end, and the downstream end in the direction of blood flow is considered the lower end.
[0040] Furthermore, the terms “first,” “second,” “third,” “fourth,” etc., are used only to distinguish descriptions and should not be interpreted as indicating or implying relative importance.
[0041] In the description of this invention, it should also be noted that, unless otherwise explicitly specified and limited, the terms "set," "install," and "connect" should be interpreted broadly. For example, they can refer to a fixed connection, a detachable connection, or an integral connection; they can refer to a direct connection or an indirect connection through an intermediate medium; and they can refer to the internal connection of two components. Those skilled in the art can understand the specific meaning of the above terms in this invention based on the specific circumstances.
[0042] The following detailed description of some embodiments of the present invention is provided in conjunction with the accompanying drawings. Unless otherwise specified, the following embodiments and features can be combined with each other.
[0043] like Figure 1 As shown, in the structure of the human heart, the mitral valve ensures that blood flows from the left atrium to the left ventricle, the tricuspid valve ensures that blood flows from the right atrium to the right ventricle, the interatrial septum is the tissue between the left and right atria, the mitral annulus is the intersection of the tissues between the left atrium, left ventricle and mitral valve leaflets, and the tricuspid annulus is the intersection of the tissues between the right atrium, right ventricle and tricuspid valve leaflets.
[0044] Transcatheter heart valve replacement involves inserting a sheath into the patient's heart to deliver an artificial heart valve prosthesis to the valve area and open it, thereby completing the artificial valve placement and restoring valve function. Transcatheter mitral valve replacement and transcatheter tricuspid valve replacement are used to treat congenital mitral stenosis or regurgitation, as well as tricuspid stenosis or regurgitation.
[0045] Based on this, the present invention provides a catheter-delivered artificial heart valve stent, a double-layered artificial heart valve stent, and two artificial heart valve prostheses.
[0046] Example 1
[0047] Reference Figures 2 to 7This embodiment provides an artificial heart valve prosthesis, which includes a double-layered artificial heart valve frame and leaflets 30. The double-layered artificial heart valve frame includes an inner stent 20 and an outer stent 10, with the inner stent 20 located within the outer stent 10. The leaflets 30 are connected to the inner stent 20, and either artificial mitral or artificial tricuspid leaflets can be selected as needed. (See also...) Figures 2 to 6 The external stent 10 is an artificial heart valve stent, and its specific structure is as follows: The external stent 10 includes a skeleton, an upper anchoring structure 12, and a lower anchoring structure 13; wherein, the skeleton includes a valve stent body 11; the upper anchoring structure 12 is connected to the upper end of the skeleton and extends to the outside of the valve stent body 11; the lower anchoring structure 13 is connected to the lower end of the skeleton and extends to the outside of the valve stent body 11; when the external stent 10 changes to a radially contracted state, the upper anchoring structure 12 elastically folds downward and closer to the valve stent body 11; the lower anchoring structure 13 elastically folds upward and closer to the valve stent body 11. The specific structure of the valve stent body 11 can be varied, for example as follows... Figures 2 to 6 The inner stent 20 is located within the valve body 11 of the outer stent 10, and may be formed in a grid-like cylindrical shape, or in a ring or spiral shape (not shown), or other structures that can be radially compressed and radially expanded upon release into the patient's valve area.
[0048] Preferably, but not limited to, in the radially contracted state of the double-layer artificial heart valve stent, the axial length of the valve body 11 of the outer stent 10 is not greater than the axial length of the inner stent 20, and preferably the two axial lengths are equivalent, so that the overall axial length of the artificial heart valve prosthesis is minimized after radial contraction.
[0049] In this embodiment, the inner stent 20 can be fixed or integrally connected with the outer stent 10, and be delivered and released simultaneously during implantation. Alternatively, the inner stent 20 can be a separate structure from the outer stent 10, in which case the outer stent 10 is delivered and released first, and then the inner stent 20 is delivered and released into the outer stent 10.
[0050] When the inner support 20 can be fixed or integrally connected to the outer support 10, there are various specific structural forms for the inner support 20, such as, but not limited to, Figure 7As shown, the main body of the inner stent 20 includes at least a plurality of V-shaped main stent units 21 connected end to end in the circumferential direction. Each V-shaped main stent unit 21 has a connecting hole 221 at its top and bottom. The main body of the inner stent 20 is fixedly connected to the inside of the valve frame body 11 of the outer stent 10 through the connecting holes 221. The connection method can be, but is not limited to, suture, mechanical connection, or welding to connect the main body of the inner stent 20 and the valve frame body 11 at the connecting holes 221. Furthermore, based on the V-shaped main stent units 21, but not limited to, additional V-shaped, rhomboid, or other curved auxiliary beams 22 can be provided to increase the support force of the inner stent 20. In particular, as those skilled in the art should know, in this embodiment, the structural form of the inner stent 20 is not limited to this. The main body of the inner stent 20 can also be other hollow stents, and the main body of the inner stent 20 can also have additional structures such as barbs to pierce the original valve leaflet after implantation, thereby enhancing post-implantation stability.
[0051] Example 2
[0052] This embodiment provides a double-layer artificial heart valve stent, which can be used as the double-layer artificial heart valve stent in Embodiment 1. The double-layer artificial heart valve stent includes an inner stent 20 and an outer stent 10, with the inner stent 20 located within the valve body 11 of the outer stent 10. A structural view of the outer stent 10 can be found in [reference needed]. Figures 2 to 6 Based on its variations and the relevant description in Embodiment 1, it specifically includes a skeleton, an upper anchoring structure 12, and a lower anchoring structure 13. The skeleton includes a valve frame body 11. The upper anchoring structure 12 is connected to the upper end of the skeleton and extends to the outside of the valve frame body 11. The lower anchoring structure 13 is connected to the lower end of the skeleton and extends to the outside of the valve frame body 11. When the outer stent 10 changes to a radially contracted state, the upper anchoring structure 12 elastically folds downwards and towards the valve frame body 11; the lower anchoring structure 13 elastically folds upwards and towards the valve frame body 11. The inner stent 20 can be a fixed or integrally connected structure with the outer stent 10, delivered and released simultaneously during implantation. Alternatively, the inner stent 20 can be a separate structure from the outer stent 10, where the outer stent 10 is delivered and released first, and then the inner stent 20 is delivered and released into the outer stent 10.
[0053] Example 3
[0054] This embodiment provides an alternative artificial heart valve prosthesis that differs from Embodiment 1. (See also...) Figures 2 to 7 The artificial heart valve prosthesis, obtained by deformation, includes an artificial heart valve frame and leaflets 30 connected to the artificial heart valve frame. The leaflets 30 can be selected as artificial mitral leaflets or artificial tricuspid leaflets as needed.
[0055] Specifically, refer to Figures 2 to 6The aforementioned artificial heart valve includes a skeleton, an upper anchoring structure 12, and a lower anchoring structure 13. The skeleton includes a valve body 11. The upper anchoring structure 12 is connected to the upper end of the skeleton and extends to the outside of the valve body 11. The lower anchoring structure 13 is connected to the lower end of the skeleton and extends to the outside of the valve body 11. When the artificial heart valve transitions to a radially contracting state, the upper anchoring structure 12 elastically folds downwards and towards the valve body 11; the lower anchoring structure 13 elastically folds upwards and towards the valve body 11. The specific structure of the valve body 11 can vary, for example, as shown below. Figures 2 to 6 The grid-like cylindrical shape shown, or formed as an annular or spiral shape (not shown) or other structures that can be radially compressed and radially expanded open after release into the patient's valve area.
[0056] Example 4
[0057] This embodiment provides an artificial heart valve stent, which can be used as the external stent 10 in Embodiments 1 and 2, and also as the artificial heart valve stent in Embodiment 3. Its structure can be referred to. Figures 2 to 6 And its deformation is obtained.
[0058] Specifically, refer to Figures 2 to 6 The artificial heart valve stent provided in this embodiment includes a skeleton, an upper anchoring structure 12, and a lower anchoring structure 13. The skeleton includes a valve stent body 11. The upper anchoring structure 12 is connected to the upper end of the skeleton and extends to the outside of the valve stent body 11. The lower anchoring structure 13 is connected to the lower end of the skeleton and extends to the outside of the valve stent body 11. When the artificial heart valve stent changes to a radially contracting state, the upper anchoring structure 12 elastically folds downwards and towards the valve stent body 11; the lower anchoring structure 13 elastically folds upwards and towards the valve stent body 11. The specific structure of the valve stent body 11 can vary, for example, as shown below. Figures 2 to 6 The grid-like cylindrical shape shown, or formed as an annular or spiral shape (not shown) or other structures that can be radially compressed and radially expanded open after release into the patient's valve area.
[0059] Whether used as the external stent 10 in Embodiments 1 and 2, or as the artificial heart valve stent in Embodiment 3, this embodiment can achieve the following beneficial effects:
[0060] (1) The upper anchoring structure 12 and the lower anchoring structure 13 perform the anchoring function after release. During delivery, the artificial heart valve retracts radially within the delivery sheath. At this time, the upper anchoring structure 12 of the artificial heart valve folds down and closer to the valve body 11, and the lower anchoring structure 13 folds up and closer to the valve body 11. As a result, the axial length of the artificial heart valve after retraction is shorter, and the length of the hard segment of the delivery sheath after passing through the interatrial septum is smaller and more flexible. The angle adjustment is easier, and even a smaller left atrium can achieve a larger angle adjustment, which improves the adaptability of transseptal puncture implantation of valve prostheses to complex cases and anatomical structures.
[0061] (2) It can also be implanted through the apex of the heart. Regardless of which approach is chosen, the shorter length of the artificial heart valve after contraction can also result in a shorter distance for the delivery sheath to retract during release, which can release faster and reduce the problem of inaccurate anchoring caused by release. All of these greatly reduce the difficulty of the operation, reduce the degree of damage to the patient's tissues, and reduce the risk of the operation.
[0062] (3) After implantation and release into the valve region between the atrium and ventricle, the upper anchoring structure 12 and the lower anchoring structure 13 rebound after being released. The upper anchoring structure 12 and the lower anchoring structure 13 clamp the patient's valve annulus and fit into the heart tissue at the expected release position. This causes no trauma to the heart tissue, and the implantation can achieve long-term anchoring. In addition, it maintains the structural shape of the artificial heart valve prosthesis and provides long-term stable support for the various functions of the artificial heart valve.
[0063] In summary, the first aspect of this embodiment provides an artificial heart valve stent (Embodiment 4); the second aspect provides a double-layer artificial heart valve stent (Embodiment 2), which includes an inner stent 20 and an outer stent 10, the outer stent 10 being the artificial heart valve stent provided in the first aspect, and the inner stent 20 being located within the valve body 11 of the outer stent 10; the third and fourth aspects respectively provide an artificial heart valve prosthesis (Embodiment 1 and Embodiment 3). The artificial heart valve prosthesis provided in the third aspect (Embodiment 1) includes the double-layer artificial heart valve stent provided in the second aspect and leaflets 30 connected to its inner stent 20, and the artificial heart valve prosthesis provided in the fourth aspect (Embodiment 3) includes the artificial heart valve stent provided in the first aspect and leaflets 30 connected to the artificial heart valve stent. The structures of the various embodiments of the present invention are based on the artificial heart valve stent structure provided in Embodiment 4, alleviating the technical problem that the existing valve stents are too long after compression, affecting the success rate of surgical operations and the feasibility of surgery via the transseptal puncture approach, while also reducing surgical risks.
[0064] Furthermore, the artificial heart valve stents described in each of the above embodiments one to four also have a variety of optional structures:
[0065] First, in this embodiment, the framework of the artificial heart valve stent includes the valve stent body 11, meaning the framework may only include the valve stent body 11. Alternatively, in addition to the valve stent body 11, the framework may also include other connecting structures, preferably but not limited to, such as... Figure 2 As shown, its skeleton, in addition to the main body 11 of the petiole frame, also includes a curved portion 111 connected to the upper end of the main body 11 of the petiole frame; the curved portion 111 includes an upper curved section extending radially outward and downward and a lower curved section extending radially inward and downward from the lower end of the upper curved section; the upper anchoring structure 12 is connected to its upper curved section. The structural design of the bend 111 allows the artificial heart valve to compress radially inward and elongate axially along the valve body 11 when it is radially contracted inside the delivery sheath. This pulls the upper anchoring structure 12 downward and towards the valve body 11 for elastic folding. This design facilitates the rapid folding of the upper anchoring structure 12 and improves the fit between the upper anchoring structure 12 and the valve body 11 under radial compression. It also reduces the diameter of the delivery sheath required for implantation, making it easier for the sheath to pass through tortuous blood vessels. Furthermore, the structural design of the bend 111 also allows the artificial heart valve to be secured in the atrium after implantation and release, thereby enhancing the anchoring function of the artificial heart valve after release.
[0066] Furthermore, in the optional structure of the artificial heart valve, preferably, in the radially contracted state of the artificial heart valve, the upper anchoring structure 12 and the lower anchoring structure 13 overlap radially inward and outward in the valve body 11, so that the artificial heart valve forms a three-layer structure in the radially contracted state, with the upper anchoring structure 12, the lower anchoring structure 13, and the valve body 11 radially overlapping, further shortening the axial length of the hard segment after the valve body 11 is radially contracted. Preferably, when the artificial heart valve is in a radially contracted state, the lower anchoring structure 13 is located inside the upper anchoring structure 12 in the radial direction of the valve body 11. When this structure is combined with the aforementioned structure in which a curved portion 111 is provided at the upper end of the valve body 11 and bulges outward in the radial direction of the valve body 11, it has the effect of strengthening the fit between the lower anchoring structure 13 and the valve body 11. Thus, both the upper anchoring structure 12 and the lower anchoring structure 13 are fitted or nearly fitted to the valve body 11, further reducing the diameter of the delivery sheath required during implantation, making it easier for the sheath to pass through tortuous blood vessels.
[0067] Preferably, the axial lengths of the upper anchoring structure 12 and the lower anchoring structure 13 are not greater than the axial length of the skeleton when the artificial heart valve is in radial contraction state, so as to minimize the overall axial length of the artificial heart valve during radial compression.
[0068] There are various options for the specific structural forms of the upper anchoring structure 12 and the lower anchoring structure 13 of this artificial heart valve stent, among which, preferred but not limited to, are, for example... Figures 2 to 6 As shown, both the upper anchoring structure 12 and the lower anchoring structure 13 are crown-shaped structures. The petal roots of each petal unit of the upper anchoring structure 12 are connected to the upper end of the skeleton, and the petal tips are arc-shaped free ends. Similarly, the petal roots of each petal unit of the lower anchoring structure 13 are connected to the lower end of the skeleton, and the petal tips are arc-shaped free ends. The specific connection methods for the petal roots to the upper or lower end of the skeleton include, but are not limited to, integral molding, physical snap-fit connection via steel sleeves or other components, or connection via welding or other methods. After connection, the upper anchoring structure 12 and the lower anchoring structure 13 can elastically fold over using their respective connection points as base points. In the released free state, the upper anchoring structure 12 unfolds downwards in a near-horizontal position, and the lower anchoring structure 13 unfolds upwards in a near-horizontal position. In some optional embodiments, the upper anchoring structure 12 or the lower anchoring structure 13 can also be the aforementioned crown-shaped connection structure individually.
[0069] The anchoring structure described above allows the upper anchoring structure 12 and the lower anchoring structure 13 to form two clamping disc structures after release, holding the valve annulus between them. This improves the stability of the artificial heart valve after implantation, ensuring it does not shift under blood flow. The valve tips of the upper anchoring structure 12 and the lower anchoring structure 13 are both arc-shaped free ends to minimize damage to the patient's heart tissue.
[0070] Further preferably, but not limited to, the upper anchoring structure 12 includes multiple V-shaped petal units 121 (open petal structures) and multiple rhomboid petal units 122 (closed petal structures); the V-shaped petal units 121 and the rhomboid petal units 122 are arranged alternately, and the two ends of the V-shaped petal units 121 are fixed or integrally connected to the adjacent rhomboid petal units 122; the inner tip of the rhomboid petal units 122 is fixed or integrally connected to the petal frame body 11.
[0071] To facilitate the connection between the outer support 10 and the inner support 20 when cooperating with the inner support 20, preferably, the inner side of the upper anchoring structure 12 is provided with an end connecting rod 123.
[0072] Finally, it should be noted that the various embodiments in this specification are described in a progressive manner, with each embodiment focusing on the differences from other embodiments. Similar or identical parts between embodiments can be referred to interchangeably. The above embodiments in this specification are only used to illustrate the technical solutions of the present invention and are not intended to limit it. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some or all of the technical features. These modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. An artificial heart valve stent, characterized in that: include: The skeleton includes a petal frame body (11). The upper anchoring structure (12) is connected to the upper end of the skeleton and extends to the outside of the petiole body (11); The lower anchoring structure (13) is connected to the lower end of the skeleton and extends to the outside of the petiole body (11); When the artificial heart valve frame changes to a radially contracted state, the upper anchoring structure (12) elastically folds downward and close to the valve frame body (11); the lower anchoring structure (13) elastically folds upward and close to the valve frame body (11). The skeleton also includes a curved portion (111) connected to the upper end of the petiole body (11); the curved portion (111) includes an upper curved section extending radially outward and downward and a lower curved section extending radially inward and downward from the lower end of the upper curved section; the upper anchoring structure (12) is connected to the upper curved section.
2. The artificial heart valve stent according to claim 1, characterized in that: In the radially contracted state of the artificial heart valve, the upper anchoring structure (12) and the lower anchoring structure (13) overlap radially inside and outside the valve body (11).
3. The artificial heart valve stent according to claim 2, characterized in that: In the radially contracted state of the artificial heart valve, in the radial direction of the valve body (11): the lower anchoring structure (13) is located inside the upper anchoring structure (12).
4. The artificial heart valve stent according to claim 1, characterized in that: In the radially contracted state of the artificial heart valve, the axial lengths of both the upper anchoring structure (12) and the lower anchoring structure (13) are not greater than the axial length of the skeleton.
5. The artificial heart valve stent according to claim 1, characterized in that: The upper anchoring structure (12) is a corolla-shaped structure, with the petal roots of each petal unit connected to the upper end of the skeleton, and the petal tips being arc-shaped free ends.
6. The artificial heart valve stent according to claim 1, characterized in that: The lower anchoring structure (13) is a corolla-shaped structure, with the petal roots of each petal unit connected to the lower end of the skeleton, and the petal tips being arc-shaped free ends.
7. A double-layer artificial heart valve stent, characterized in that: It includes an inner stent (20) and an outer stent (10), wherein the outer stent (10) is an artificial heart valve stent according to any one of claims 1-6; The inner support (20) is located inside the petiole body (11).
8. The double-layer artificial heart valve stent according to claim 7, characterized in that: In the radially contracted state of the double-layer artificial heart valve stent, the axial length of the valve body (11) of the outer stent (10) is not greater than the axial length of the inner stent (20).
9. An artificial heart valve prosthesis, characterized in that: Includes the double-layer artificial heart valve frame as described in claim 7 or 8 and the leaflet (30) connected to the inner stent (20).
10. An artificial heart valve prosthesis, characterized in that: It includes the artificial heart valve frame as described in any one of claims 1-6 and the leaflet (30) connected to the artificial heart valve frame.
Citation Information
Patent Citations
Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
CN103974674A
Split type cardiac valve stent and prosthesis thereof
CN111110398A
Artificial valve stent, artificial valve prosthesis and release method
CN117122449A